Cartesian Therapeutics Inc (NAS:RNAC)
$ 22 0.97 (4.61%) Market Cap: 391.15 Mil Enterprise Value: 307.95 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Cartesian Therapeutics Inc (RNAC) Stock Estimates Data

Cartesian Therapeutics Inc (RNAC) 12 Month Price Targets

Cartesian Therapeutics Inc (RNAC) Analyst Rating